Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Stada Arzneimittel AG
Nidda Healthcare Holding AG
2020-2
Nidda Healthcare Holding AG (NDDHC) 2020-2
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
NDDHC 2020-2 (EUR 200m)
Stada Arzneimittel AG
CTI
,
BRC
,
CMZ
,
DEU
,
...
EMEA
May 5, 2020
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
PVM
229.000
5.9
Jul-09
Si. Svnyivm
L2
U
U+
Vkoxb
A
94.00-94.50
-
571
3.50%
-
55.30000
Tranche Comments
4.5 zc: Redemption: 2020-09-30; Registration: 144D/Cmf R; Comments: UOX200l zo-oxow jnn-oz oa 1.085fz 3.5% Vxf 2024 (Cjqqm axol 9/20 50%/25%/fjx). U2/U/U+. Qalm Cdtd(U&Y)/YU. KUm Ujxf/CME/HDX/Kxaa/KQM/MV/Dolaxj/VX/OUV. Yjqm 94.00-94.50, MLC U+50. Uazn 1% 8/24+571. +KH.;
Use of Proceeds
Einihqm xoheohqai ezheogig
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.